# Diabetes Drug Acarbose May Calm Severe Allergies By Reshaping Gut Bacteria

*Acarbose redirects gut microbiome utilization of dietary carbohydrates to suppress anaphylaxis in mice.*

- **Evidence Level**: Preliminary
- **Publication Types**: Journal Article
- **Journal**: Nature microbiology
- **Sample Size**: Mouse study plus human cohort analysis
- **Authors**: Yakabe K, Inoue Y, Yanagisawa Y, Imai S, Suwa S, Ando M, Wu Y, Kurokawa R, Tanakorn S, Haneda T, Miki T, Ito M, Hirayama A, Kurashima Y, Fukuda S, Hase K, Suda W, Takeyama H, Hori S, Kim YG
- **Published**: 2026-05-12
- **Topics**: gut microbiome, allergies, drug repurposing
- **DOI**: https://doi.org/10.1038/s41564-026-02350-2
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42120908/

## Summary

In mice, the diabetes drug acarbose changed how gut bacteria use carbs, boosting a microbe that produces succinate. That succinate then blocked the mast cell reactions behind severe allergic shock. A look at human records found people taking similar drugs had fewer anaphylaxis cases.

## Practical Takeaway

This study hints that gut bacteria metabolites like succinate may shape allergic responses.

---

_Canonical: https://usa-longevity.com/en/research/diabetes-drug-acarbose-may-calm-severe-allergies-by-reshaping-gut-bacteria · Part of Longevity Cities · Updated 2026-05-12_